What's Jeffrey Knapp's mailing address?
Jeffrey's mailing address filed with the SEC is C/O ADAMAS PHARMACEUTICALS, INC., 1900 POWELL ST., SUITE 750, EMERYVILLE, CA, 94608.
Wallmine is a radically better financial terminal.
Sign up in seconds, it's free!
Wallmine is a radically better financial terminal.
Sign up in seconds, it's free!
Wallmine is a radically better financial terminal.
Sign up in seconds, it's free!
Insiders trading at Aimmune Therapeutics Inc
Over the last 9 years, insiders at Aimmune Therapeutics Inc have traded over $19,285,948 worth of Aimmune Therapeutics Inc stock and bought 61,698,079 units worth $2,225,231,200 . The most active insiders traders include Des Produits Nestle S.A. So..., Patrick G Enright, and Des Produits Nestle S.A.Nes.... On average, Aimmune Therapeutics Inc executives and independent directors trade stock every 22 days with the average trade being worth of $21,038,606. The most recent stock trade was executed by Des Produits Nestle S.A. So... on 13 October 2020, trading 54,117,287 units of AIMT stock currently worth $1,867,046,402.
What does Aimmune Therapeutics Inc's logo look like?
Aimmune Therapeutics Inc executives and stock owners
Aimmune Therapeutics Inc executives and other stock owners filed with the SEC include:
-
Stacey Denenberg Seltzer,
Director -
Jeffrey H Knapp,
Chief Operating Officer -
Susan E. Barrowcliffe,
General Manager, Europe -
Capital Partners Ii, Llc Ta...,
-
Kathryn E Falberg,
Director -
Daniel C Md Adelman,
Chief Medical Officer -
Mary M. Rozenman,
See Remarks -
Capital Management Ii, Llc ...,
-
Capital Partners Ii, Llc Lo...,
-
Gregory Behar,
Director -
Douglas T. Sheehy,
See Remarks -
Mark T Iwicki,
Director -
Eric Bjerkholt,
Chief Financial Officer -
Mark Mcdade,
Director -
Warren L. De Souza,
Chief Financial Officer -
Robert Myles Elfont,
Chief Medical Officer -
Jayson Donald Alexander Dallas,
President and CEO -
Health Science Us Holdings,...,
-
Des Produits Nestle S.A.Nes...,
-
Bakker Juliet Tammenoms,
10% owner -
Stephen George Dilly,
See Remarks -
Andrew Oxtoby,
Chief Commercial Officer -
Capital Partners Ii, Llc Ta...,
-
Patrick G Enright,
Director -
Brett K Haumann,
Director -
Des Produits Nestle S.A. So...,
10% owner